Synergistic Combination of PMBA and 5-Fluorouracil (5-FU) in Targeting Mutant KRAS in 2D and 3D Colorectal Cancer Cells

Scientists investigated the effect and efficacy of 2-pyridin-4-yl methylene β-boswellic acid (PMBA) and 5-FU in combination therapy compared in the treatment of KRAS mutant colon cancer.